Interestingly, inhibition of IL-10 receptor in macrophages also reduced tumor burden in breast cancer models if combined with chemotherapy, with an equivalent effect caused by blockade of CSF-1R, in both cases associated with increased IL-12 production by intra-tumor DCs and CD8+ T cell-mediated anti-tumor activity [154]. This evidence concerns the gene CSF1R and breast carcinoma.